The Cardiowest total artificial heart: Experience of 29 cases;Coeur artificiel total Cardiowest. Experience a partir de 29 cas

Archives des Maladies du Coeur et des Vaisseaux

Volumn 91, Issue 4, 1998, Pages 397-404

  Leprince, P ^a   Pavie, A ^b   Leger, Ph ^b   Szefner, J ^b   Nataf, P ^b   Bors, V ^b   Gandjbakhch, I ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE;

ADULT; ARTICLE; ARTIFICIAL HEART; ASSISTED CIRCULATION; ASSISTED VENTILATION; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEART FAILURE; HUMAN; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PROTHROMBIN TIME; SYSTEMIC VASCULAR RESISTANCE; THROMBOCYTE COUNT; AGED; ARTIFICIAL HEART PACEMAKER; CONGESTIVE HEART FAILURE; HEART TRANSPLANTATION; MIDDLE AGED; PATHOPHYSIOLOGY; SURVIVAL;

ADULT; AGED; FEMALE; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART, ARTIFICIAL; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; SURVIVAL ANALYSIS;

EID: 0032038019     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Villemot J, Carteaux J, Bischoff N et al. Assistances uni- ou biventriculaires : critères de sélection et de surveillance des patients, choix du dispositif. Arch Mal Cœur 1996 ; 89 (spécial) : 55-63.
2. Copeland JG, Pavie A, Duveau D et al. Bridge to transplantation with the Cardiowest total artificial heart : the international experience 1993 to 1995. J Heart Lung Transplant 1996 ; 15 : 94-9.
3. Bourge RC, Naftel DC, Costanzo-Nordin MR et al. Pretransplantation risk factors for death after transplantation : a multiinstitutional study. J Heart Lung Transplant 1993 ; 12 : 549-62.
4. Registre. The registry of the international society for heart and lung transplantation : tenth official report-1993. J Heart Lung Transplant 1993 ; 12, 4 : 541-8.
5. Reedy JE, Pennington G, Miller LW et al. Status I heart transplant patients : conventional versus ventricular assist device support. J Heart Lung Transplant 1992 ; 11 : 246-52.
6. Johnson KE, Prieto M, Joyce LD et al. Summary of the clinical use of symbiom total artificial heart : a registry report. J Heart Lung Transplant 1992 ; 11 : 103-16.
7. Joyce LD, Johnson KE, Pierce WS et al. Summary of the world experience with clinical use of total artificial hearts as heart support devices. J Heart Transplant 1986 ; 5 : 229-35.
8. Griffith BP. Interim use of the Jarvik-7 artificial heart : lessons learned at presbyterian-university hospital of Pittsburgh. Ann Thorac Surg 1989 ; 47 : 158-66.
9. Szefner J. Control and treatment of hemostasis in cardiovascular surgery. Int Artif Organs 1995 ; 18 : 633-48.
10. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Am Surg 1992 ; 216, 2 : 117-34.
11. Wang X, Andersson R. The role of endothelial cells in the systemic inflammatory response syndrome and multiple system organ failure. Eur J Surg 1995 ; 161 : 703-13.
12. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ-system failure. Ann Surg 1985 ; 202 : 685-93.
13. Fry DE, Pearlstein L, Fulton RL, Polk HC. Multiple system organ failure : the role of uncontrolled infection. Arch Surg 1980 ; 115 : 136-40.
14. Beal A, Cerra F. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 1994 ; 271 : 226-33.
15. Cochrane CG. The enhancement of inflammatory injury. Am Rev Respir Dis 1987 ; 136 : 1-3.
16. Deitch EA. Review of the effect of stress and trauma on plasma fibronectin and reticuloendothelial system. J Burn Care Rehabil 1983 ; 4 : 344-41.
17. Goris R, Boekhorst TT, Nuytinck J, Gimbrère J. Multiple-organ failure. Generalized autodestructive inflammation ? Arch Surg 1985 ; 120 : 1109-15.
18. Barroso-Aranda J, Smith-Schönbein G, Zweifach B, Engler R. Granulocytes and no reflow phenomenon in irreversible hemorrhagic shock. Circ Res 1988 ; 63 : 437-47.
19. McEver R. Leukocyte-endothelial cell interactions. Curr Opin Cell Biol 1992 ; 4 : 840-9.
20. Nuytinck H, Xavier J, Offermans W et al. Whole-body inflammation in trauma patients : an autopsy study. Arch Surg 1988 ; 123 : 1519-24.
21. Gillinov A, Bator J, Zehr K. Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators. Ann Thorac Surg 1993 ; 56 : 847-53.
22. Gillinov A, Redmond J, Winkelstein J. Complement and neutrophil activation during cardiopulmonary bypass : a study in the complement-deficient dog. Ann Thorac Surg 1994 ; 57 : 345-52.
23. Selke F, Friedman M, Dai H. Mechanism causing coronary microvascular dysfunction following crystalloid cardioplegia and reperfusion. Cardiovasc Res 1993 ; 27 : 1925-32.
24. Gertler J, Weibe D, Ocasio V, Abbot W. Hypoxia induces procoagulant activity in cultured human venous endothelium. J Vasc Surg 1991 ; 13 : 428-33.
25. McMillen M, Huribal M, Sumpio B. Common pathway in endothelial-leucocyte interaction in shock, ischemia, and reperfusion. Am J Surg 1993 ; 166 : 557-62.
26. Reilly P, Schiller H, Bulkley G. Pharmacologic approach to tissue injury mediated by free radiacals and other oxygen metabolites. Am J Surg 1991 ; 161 : 488-503.
27. Loisance DY, Pouillart F, Benvenuti C et al. Mechanical bridge to transplantation : when is too early ? When is too late ? Ann Thorac Surg 1996 ; 61 : 388-90.
28. Deleuze P, Loisance D, Shiiya N et al. Irreversible drop of systemic vascular resistances in patients implanted with a Jarvik total artificial heart. Int J Artif Organs 1991 ; 14 (5) : 286-9.